You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 凱萊英漲5% 子公司凱萊英生物發展擬引入高瓴等外部投資者
格隆匯3月29日丨港股凱萊英(6821.HK)現漲5.02%,報272港元;A股凱萊英(002821.SZ)現漲2.62%,報368億元,總市值973億元。凱萊英28日發佈公吿,公司擬與海河凱萊英基金、高瓴祈睿、珠海岱恆等簽署投資協議,各投資方在凱萊英生物發展完成對凱萊英生物的全資收購後,對凱萊英生物發展進行投資並認購其新增註冊資本。各投資方將按照投資協議約定分期向凱萊英生物發展合計增資不超過約25.34億元。凱萊英生物發展未來將定位成為凱萊英醫藥集團中包括大分子藥物、抗體偶聯藥物、細胞基因治療藥物以及mRNA藥物等在內的獨家合同研發生產服務(CDMO)企業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account